http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101761983-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
filingDate 2014-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101761983-B1
titleOfInvention Fast dissolving oral thin film composite and preparing method thereof
abstract The present invention relates to a pharmaceutical composition for oral administration containing oral sustained-release microparticles containing 150 to 200 parts by weight of at least one selected from the group consisting of ethyl cellulose, ethyl cellulose and collidone, based on 100 parts by weight of fexofenadine or a pharmaceutically acceptable salt thereof, To provide a film composition. Fexofenadine or a pharmaceutically acceptable salt thereof may be formulated as sustained release microparticles to maintain an effective blood concentration in the body of a patient so that it can be taken once a day, thereby greatly increasing the convenience of medication. In addition, the application of fexofenadine can be shielded to increase the adherence of medicines, and the film formulation can easily treat patients and aged people who have decreased gingival capacity.
priorityDate 2014-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101188594-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011162531-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451905405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448413499
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135413523
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505589
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832091
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57503849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3348

Total number of triples: 39.